vimarsana.com

Page 10 - சீட்டில் புற்றுநோய் பராமரிப்பு கூட்டணி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tech Moves: Former Rover CTO joins moving startup Dolly; Egencia s CFO to depart; and more

Tech Moves: Former Rover CTO joins moving startup Dolly; Egencia’s CFO to depart; and more Geekwire 4/28/2021 © Provided by Geekwire Scott Porad. (Dolly Photo) Former Rover CTO Scott Porad joined peer-to-peer moving service Dolly as its first-ever chief technology officer. The Seattle startup operates an app that connects individuals and business to movers with trucks and equipment. “I really enjoy this period in a startup company, when they are poised on the brink of tremendous growth,” said Porad. The role is a return to the gig economy for Porad, who spent seven years helping build Rover’s pet sitting marketplace.

Washington Mesothelioma Victims Center Urges a Public Utility or Power Plant Worker with Mesothelioma Anywhere in Washington State to Call Attorney Erik Karst of Karst von Oiste-Get Better Compensation Results

Seeking to expand targeted therapy for lung cancer

Seeking to expand targeted therapy for lung cancer NIH MERIT Award will support Dr. Alice Berger’s efforts to target lung cancer-associated gene mutation April 7, 2021 • By Sabrina Richards / Fred Hutch News Service Dr. Alice Berger works to expand targeted therapy options for patients with lung cancer. Photo by Robert Hood / Fred Hutch News Service Targeted therapies have transformed outcomes for lung cancer patients. After reduced smoking rates, drugs that take aim at signature alterations in tumor cells are the main reason that the death rate has dropped for people diagnosed with lung cancer. Recently, Fred Hutchinson Cancer Research Center lung cancer researcher Dr. Alice Berger received a National Institutes of Health MERIT Award that will support her efforts to extend these advances to more patients with this cancer.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.